Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Open Forum
    • 2023 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Open Forum
    • 2023 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • The Journal
  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
Case ReportCase Reports

Endobronchial Argon Plasma Coagulation for Treatment of Dieulafoy Disease

Levent Dalar, Sinem N Sökücü, Cengiz Özdemir, Songül Büyükkale and Sedat Altın
Respiratory Care January 2015, 60 (1) e11-e13; DOI: https://doi.org/10.4187/respcare.03307
Levent Dalar
Department of Pulmonary Medicine, School of Medicine, İstanbul Bilim University, İstanbul, Turkey.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Sinem N Sökücü
Department of Interventional Pulmonology
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cengiz Özdemir
Department of Interventional Pulmonology
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Songül Büyükkale
Department of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Teaching and Research Hospital, İstanbul, Turkey.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sedat Altın
Department of Interventional Pulmonology
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

Dieulafoy disease of the bronchus is a rare condition. A 28-y-old male patient with recurrent exacerbations of hemoptysis (producing up to 300 mL) over the previous 4 y was admitted to our hospital following an acute episode. A 3-mm sessile lesion covered with somewhat ulcerated smooth mucosa was detected at the distal end of the left main bronchus, at the entrance to the upper lobe bronchus. Bleeding was controlled by argon plasma coagulation, and total coagulation of the lesion was also therapeutic. The patient has been followed for 2 y with no further bleeding. In the very few reported cases of Dieulafoy disease, surgical resection and selective embolization were the treatments used. Endobronchial treatment has not been described before as a therapeutic approach. We emphasize that argon plasma coagulation can be a treatment option in such cases.

  • Dieulafoy disease
  • bronchoscopy
  • coagulation
  • hemoptysis
  • vascular malformation

Introduction

Dieulafoy disease was first described by the French physician Dieulafoy as a vascular malformation of the stomach.1 Later, it was also defined as a rare disease of the bronchial system. The disease appears with massive and submassive hemoptysis episodes.2 On bronchoscopy, a millimeter-sized lesion covered by smooth mucosa is observed. If a lesion is detected between bleeding exacerbations, a biopsy can result in catastrophic hemorrhage.3 Experience regarding its treatment is limited to a few case reports. Surgical resection in a few cases and selective embolization in others have been used as treatments.4,5 To the best of our knowledge, endobronchial treatment to stop bleeding episodes has not been reported before. Argon plasma coagulation is a safe method for the treatment of visible hemorrhagic lesions of the tracheobronchial tree. In this case report, a lesion located at the entrance to the left upper lobe was treated by argon plasma coagulation, and no bleeding episode was observed in the following 2 y.

Case Report

A 28-y-old male patient presented with recurrent hemoptysis, sometimes with massive amounts, over the previous 4 y. The first massive hemoptysis episode occurred in 2008 and again in 2009 and 2012, with the last one producing ∼300 mL. The patient had a 1 pack-year smoking history and smoked for 5 y. Other systemic examinations and laboratory values were unremarkable. No abnormality was detected in his thoracic computed tomography scan, with no infiltration. Ground-glass areas due to aspiration of the blood were seen (Fig. 1). Although bronchoscopy had been performed several times at different centers, no lesion had been detected. In another bronchoscopy, performed in our unit following a massive hemoptysis episode, a 3-mm sessile lesion was observed at the entrance to the left upper lobe bronchus and was evaluated as a vascular malformation (Fig. 2). As in other Dieulafoydisease cases, the lesion was sessile and covered by mucosa that was partly ulcerated. The previous procedures had been performed using rigid bronchoscopy. However, when a flexible bronchoscope was passed through the rigid bronchoscope, the lesion was reached properly. The power setting during argon plasma coagulation was 40 W, and the continuous mode was used. Using a flexible argon plasma coagulation probe, the base and then the surface of the lesion were coagulated (Fig. 3). The total duration of the procedure was 20 min. In a follow-up bronchoscopy performed 10 d later, the lesion had resolved, and no other lesion was observed. The patient did not agree to any further investigation, such as selective bronchial angiography (which can show abnormal bronchial artery formation) or gastrointestinal endoscopic imaging (to assess any other vascular malformation in the gastrointestinal tract).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Thoracic computed tomography sections. There is no remarkable lesion that can explain the hemoptysis.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Rigid bronchoscopy revealed a large coagulum in the trachea. After bronchoscopic cleaning, a small lesion could be seen at the entrance to the left upper lobe (arrow).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

The lesion was coagulated and carbonized by argon plasma coagulation during the same session in which the lesion was visualized.

There has been controversy regarding the diagnosis of Dieulafoy disease of the bronchus. However, there are no well-defined criteria to establish a diagnosis of bronchial Dieulafoy disease because of its rarity. Nonetheless, the lack of selective bronchial angiography is accepted as a limitation for a definitive diagnosis. In the present case, the lesion at the entrance to the left upper lobe was clearly vascular in nature, and the result of the therapy confirmed the diagnosis. The patient's medical history did not include any gastrointestinal bleeding. No acute hemoptysis was observed in the 2 y after argon plasma coagulation, and the patient is still being followed.

Discussion

Dieulafoy disease was first defined in the gastrointestinal system. Any part of the gastrointestinal system can be affected.6 Dieulafoy disease of the bronchus is a rare disease. Very few cases have been reported in English medical literature.3,4 The small number of cases may be partly due to the fact that it is difficult to detect the lesion bronchoscopically, and the lesion may be missed even when several bronchoscopies are done, as in this case.

Surgical treatments have been reported in some cases, and in others, good results have been obtained with embolization. To the best of our knowledge, no case treated by an endobronchial approach, including the gastrointestinal tract, has been reported.6 Argon plasma coagulation has a lower penetration depth and is selectively oriented to the bleeding area; it is a frequently used method for visible hemorrhagic lesions of the tracheobronchial tree. Although the use of argon plasma coagulation is generally safe, a major complication can be air emboli.7 Unlike laser use, argon plasma coagulation does not cause serious complications, such as perforations or major secondary bleeding. For this reason, it is frequently used in connection with mechanical resections of malignant obstructive lesions and benign tumors of the airways. It can also be used safely for eradication of basal areas of resected tumors.

The efficacy of bronchoscopic laser treatments of vascular malformations has long been known, since the first endobronchial laser applications.8 However, argon plasma coagulation was not considered a treatment option for these patients. Coagulation of the whole surface, starting from the basal area of the lesion, causes shrinkage of the lesion. In this way, the bleeding point is covered. In the healing phase, significant scars in the submucosal layer provide long-term bleeding control. In this case, one application of argon plasma coagulation was sufficient for long-term bleeding control. The lesion resolved, and no stricture remained in a follow-up bronchoscopic exam in the healing phase. The extension of the bronchus through the submucosal layer can help to coagulate a widened bronchial artery with this method. In some cases, more than one lesion has been seen at the mucosa. It may be more appropriate to use embolization or surgery as the treatment option rather than argon plasma coagulation in such cases.

Endobronchial Dieulafoy disease is a rarely seen entity. Due to their small sizes and and covered with coagulum, associated lesions may be rarely recognized, and this could have fatal results. In such cases with no apparent lesion, a very careful bronchoscopic evaluation is essential. In conclusion, in addition to successful treatment options, such as surgery and selective embolization, argon plasma coagulation should also be kept in mind as a safe and effective method.

Footnotes

  • Correspondence: Levent Dalar MD, Sisli Florence Nightingale Hospital, Abidei Hurriyet Cad No: 164, Kat: 2D, 34380 İstanbul, Turkey. E-mail: leventdalar{at}gmail.com.
  • The authors have disclosed no conflicts of interest.

  • Copyright © 2015 by Daedalus Enterprises

References

  1. 1.↵
    1. Veldhuyzen van Zanten SJ,
    2. Bartelsman JF,
    3. Schipper ME,
    4. Tytgat GN
    . Recurrent massive haematemesis from Dieulafoy vascular malformation: a review of 101 cases. Gut 1986;27(2):213–222.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Sakr L,
    2. Dutau H
    . Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. Respiration 2010;80(1):38–58.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Löschhorn C,
    2. Nierhoff N,
    3. Mayer R,
    4. Zaunbauer W,
    5. Neuweiler J,
    6. Knoblauch A
    . Dieulafoy's disease of the lung: a potential disaster for the bronchoscopist. Respiration 2006;73(4):562–565.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Barisione EE,
    2. Ferretti GG,
    3. Ravera SS,
    4. Salio MM
    . Dieulafoy's disease of the bronchus: a possible mistake. Multidiscip Respir Med 2012;7(1):40.
    OpenUrlPubMed
  5. 5.↵
    1. Bhatia P,
    2. Hendy MS,
    3. Li-Kam-Wa E,
    4. Bowyer PK
    . Recurrent embolotherapy in Dieulafoy's disease of the bronchus. Can Respir J 2003;10(6):331–333.
    OpenUrlPubMed
  6. 6.↵
    1. Lim W,
    2. Kim TO,
    3. Park SB,
    4. Rhee HR,
    5. Park JH,
    6. Bae JH,
    7. et al
    . Endoscopic treatment of Dieulafoy lesions and risk factors for rebleeding. Korean J Intern Med 2009;24(4):318–322.
    OpenUrlPubMed
  7. 7.↵
    1. Reddy C,
    2. Majid A,
    3. Michaud G,
    4. Feller-Kopman D,
    5. Eberhardt R,
    6. Herth F,
    7. Ernst A
    . Gas embolism following bronchoscopic argon plasma coagulation: a case series. Chest 2008;134(5):1066–1069.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Dumon JF,
    2. Corsini A
    . Aspects pratiques de la resection endoscopique au laser en bronchologie. Marseille, France: Centre Laser et Service d'Endoscopie Bronchique; 1988:1–5.
PreviousNext
Back to top

In this issue

Respiratory Care: 60 (1)
Respiratory Care
Vol. 60, Issue 1
1 Jan 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Monthly Podcast

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Endobronchial Argon Plasma Coagulation for Treatment of Dieulafoy Disease
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Endobronchial Argon Plasma Coagulation for Treatment of Dieulafoy Disease
Levent Dalar, Sinem N Sökücü, Cengiz Özdemir, Songül Büyükkale, Sedat Altın
Respiratory Care Jan 2015, 60 (1) e11-e13; DOI: 10.4187/respcare.03307

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Endobronchial Argon Plasma Coagulation for Treatment of Dieulafoy Disease
Levent Dalar, Sinem N Sökücü, Cengiz Özdemir, Songül Büyükkale, Sedat Altın
Respiratory Care Jan 2015, 60 (1) e11-e13; DOI: 10.4187/respcare.03307
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Case Report
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Keywords

  • Dieulafoy disease
  • bronchoscopy
  • coagulation
  • hemoptysis
  • vascular malformation

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire